|
1
|
Wilson PW, Bozeman SR, Burton TM, Hoaglin
DC, Ben-Joseph R and Pashos CL: Prediction of first events of
coronary heart disease and stroke with consideration of adiposity.
Circulation. 118:124–130. 2008.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Jehan S, Myers AK, Zizi F, Pandi-Perumal
SR, Jean-Louis G and McFarlane SI: Obesity, obstructive sleep apnea
and type 2 diabetes mellitus: Epidemiology and pathophysiologic
insights. Sleep Med Disord. 2:52–58. 2018.PubMed/NCBI
|
|
3
|
Faria SL, Faria OP, Menezes CS, de Gouvêa
HR and de Almeida Cardeal M: Metabolic profile of clinically severe
obese patients. Obes Surg. 22:1257–1262. 2012.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Jéquier E and Tappy L: Regulation of body
weight in humans. Physiol Rev. 79:451–480. 1999.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Moseti D, Regassa A and Kim WK: Molecular
regulation of adipogenesis and potential anti-adipogenic bioactive
molecules. Int J Mol Sci. 17(124)2016.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Rosen ED, Hsu CH, Wang X, Sakai S, Freeman
MW, Gonzalez FJ and Spiegelman BM: C/EBPalpha induces adipogenesis
through PPARgamma: A unified pathway. Genes Dev. 16:22–26.
2002.PubMed/NCBI View Article : Google Scholar
|
|
7
|
El-Jack AK, Hamm JK, Pilch PF and Farmer
SR: Reconstitution of insulin-sensitive glucose transport in
fibroblasts requires expression of both PPARgamma and C/EBPalpha. J
Biol Chem. 274:7946–7951. 1999.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Lefterova MI and Lazar MA: New
developments in adipogenesis. Trends Endocrinol Metab. 20:107–114.
2009.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Tanaka T, Yoshida N, Kishimoto T and Akira
S: Defective adipocyte differentiation in mice lacking the
C/EBPbeta and/or C/EBPdelta gene. EMBO J. 16:7432–7443.
1997.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Clarke SL, Robinson CE and Gimble JM:
CAAT/enhancer binding proteins directly modulate transcription from
the peroxisome proliferator-activated receptor gamma2 promoter.
Biochem Biophys Res Commun. 240:99–103. 1997.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Farmer SR: Transcriptional control of
adipocyte formation. Cell Metab. 4:263–273. 2006.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Wei S, Zan LS, Wang HB, Cheng G, Du M,
Jiang Z, Hausman GJ, Mcfarland DC and Dondson MV:
Adenovirus-mediated interference of FABP4 regulates mRNA expression
of ADIPOQ, LEP and LEPR in bovine adipocytes. Genet Mol Res.
12:494–505. 2019.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Rosen ED, Walkey CJ, Puigserver P and
Spiegelman BM: Transcriptional regulation of adipogenesis. Genes
Dev. 14:1293–1307. 2000.PubMed/NCBI
|
|
14
|
Tseng YH, Butte AJ, Kokkotou E, Yechoor
VK, Taniguchi CM, Kriauciunas KM, Cypess AM, Niinobe M, Yoshikawa
K, Patti ME and Kahn CR: Prediction of preadipocyte differentiation
by gene expression reveals role of insulin receptor substrates and
necdin. Nat Cell Biol. 7:601–611. 2005.PubMed/NCBI View
Article : Google Scholar
|
|
15
|
Prusty D, Park BH, Davis KE and Farmer SR:
Activation of MEK/ERK signaling promotes adipogenesis by enhancing
peroxisome proliferator-activated receptor gamma (PPARgamma) and
C/EBPalpha gene expression during the differentiation of 3T3-L1
preadipocytes. J Biol Chem. 277:46226–46232. 2002.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Guo LX, Chen G, Yin ZY, Zhang YH and Zheng
XX: P-Synephrine exhibits anti-adipogenic activity by activating
the Akt/GSK3β signaling pathway in 3T3-L1 adipocytes. J Food
Biochem. 43(e13033)2019.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Powell AG, Apovian CM and Aronne LJ: New
drug targets for the treatment of obesity. Clin Pharmacol Ther.
90:40–51. 2011.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Yanovski SZ and Yanovski JA: Long-term
drug treatment for obesity: A systematic and clinical review. JAMA.
311:74–86. 2014.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Kumar P and Bhandari U: Common medicinal
plants with antiobesity potential: A special emphasis on fenugreek.
Anc Sci Life. 35:58–63. 2015.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Hatano T, Sameshima Y, Kawabata M, Yamada
S, Shinozuka K, Nakabayashi T and Mizuno H: St. John's wort
promotes adipocyte differentiation and modulates NF-κB activation
in 3T3-L1 cells. Biol Pharm Bull. 37:1132–1138. 2014.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Mikaili P, Maadirad S, Moloudizargari M,
Aghajanshakeri S and Sarahroodi S: Therapeutic uses and
pharmacological properties of garlic, shallot, and their
biologically active compounds. Iran J Basic Med Sci. 16:1031–1048.
2013.PubMed/NCBI
|
|
22
|
Kim HJ, Lee MJ, Jang JY and Lee SH:
Allium hookeri root extract inhibits adipogenesis by
promoting lipolysis in high fat diet-induced obese mice. Nutrients.
11(2262)2019.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Kagawa Y, Ozaki-Masuzawa Y, Hosono T and
Seki T: Garlic oil suppresses high-fat diet induced obesity in rats
through the upregulation of UCP-1 and the enhancement of energy
expenditure. Exp Ther Med. 19:1536–1540. 2020.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Xu C, Mathews AE, Rodrigues C, Eudy BJ,
Rowe CA, O'Donoughue A and Percival SS: Aged garlic extract
supplementation modifies inflammation and immunity of adults with
obesity: A randomized, double-blind, placebo-controlled clinical
trial. Clin Nutr ESPEN. 24:148–155. 2018.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Stoll A and Seeback E: Chemical
investigations on alliin, the specific principle of garlic. Adv
Enzymol Relat Subj Biochem. 11:377–400. 1951.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Slusarenko AJ, Patel A and Portz D:
Control of plant diseases by natural products: Allicin from garlic
as a case study. Eur J Plant Pathol. 121:313–322. 2008.
|
|
27
|
Borlinghaus J, Albrecht F, Gruhlke MC,
Nwachukwu ID and Slusarenko AJ: Allicin: Chemistry and biological
properties. Molecules. 19:12591–12618. 2014.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Upadhyay RK: Garlic: A potential source of
pharmaceuticals and pesticides: A review. Int J Green Phar.
10:1–28. 2016.
|
|
29
|
Quintero-Fabián S, Ortuño-Sahagún D,
Vázquez-Carrera M and López-Roa RI: Alliin, a Garlic (Allium
sativum) compound, prevents LPS-induced inflammation in 3T3-L1
adipocytes. Mediators Inflamm. 2013(381815)2013.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Zhang M, Sheng S, Zhang W, Zhang J, Zhang
Z, Zhang M, Hatch GM and Chen L: MiR27a promotes the development of
macrophage-like characteristics in 3T3-L1 preadipocytes. Int J Biol
Sci. 14:1599–1609. 2018.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408.
2001.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Ekor M: The growing use of herbal
medicines: Issues relating to adverse reactions and challenges in
monitoring safety. Front Pharmacol. 4(177)2014.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Aoyagi R, Funakoshi-Tago M, Fujiwara Y and
Tamura H: Coffee inhibits adipocyte differentiation via
inactivation of PPARγ. Biol Pharm Bull. 37:1820–1825.
2014.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Liao CC, Ou TT, Huang HP and Wang CJ: The
inhibition of oleic acid induced hepatic lipogenesis and the
promotion of lipolysis by caffeic acid via up-regulation of
AMP-activated kinase. J Sci Food Agric. 94:1154–1162.
2014.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Wu T, Jiang Z, Yin J, Long H and Zheng X:
Anti-obesity effects of artificial planting blueberry (Vaccinium
ashei) anthocyanin in high-fat diet-treated mice. Int J Food Sci
Nutr. 67:257–264. 2016.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Prins JB and O'Rahilly S: Regulation of
adipose cell number in man. Clin Sci (Lond). 92:3–11.
1997.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Guo L, Li X and Tang QQ: Transcriptional
regulation of adipocyte differentiation: A central role for
CCAAT/enhancer-binding protein (C/EBP) β. J Biol Chem. 290:755–761.
2015.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Salma N, Xiao H and Imbalzano AN: Temporal
recruitment of CCAAT/enhancer-binding proteins to early and late
adipogenic promoters in vivo. J Mol Endocrinol. 36:139–151.
2006.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Tontonoz P, Hu E and Spiegelman BM:
Stimulation of adipogenesis in fibroblasts by PPARgamma2, a
lipid-activated transcription factor. Cell. 79:1147–1156.
1994.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Wang F, Mullican SE, DiSpirito JR, Peed LC
and Lazar MA: Lipoatrophy and severe metabolic disturbance in mice
with fat-specific deletion of PPARγ. Proc Natl Acad Sci USA.
110:18656–18661. 2013.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Illesca P, Valenzuela R, Espinosa A,
Echeverría F, Soto-Alarcon S, Ortiz M and Videla LA: Hydroxytyrosol
supplementation ameliorates the metabolic disturbances in white
adipose tissue from mice fed a high-fat diet through recovery of
transcription factors Nrf2, SREBP-1c, PPAR-γ and NF-κB. Biomed
Pharmacother. 109:2472–2481. 2019.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Echeverría F, Ortiz M, Valenzuela R and
Videla LA: Long-chain polyunsaturated fatty acids regulation of
PPARs, signaling: Relationship to tissue development and aging.
Prostaglandins Leukot Essent Fatty Acids. 114:28–34.
2016.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Wu Z, Rosen ED, Brun R, Hauser S, Adelmant
G, Troy AE, McKeon C, Darlington GJ and Spiegelman BM:
Cross-regulation of C/EBPα and PPARγ controls the transcriptional
pathway of adipogenesis and insulin sensitivity. Mol Cell.
3:151–158. 1999.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Tang QQ, Otto TC and Lane MD:
CCAAT/enhancer-binding protein beta is required for mitotic clonal
expansion during adipogenesis. Proc Natl Acad Sci USA. 100:850–855.
2003.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Ghaben AL and Scherer PE: Adipogenesis and
metabolic health. Nat Rev Mol Cell Biol. 20:242–258.
2019.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Gerhold DL, Liu F, Jiang G, Li Z, Xu J, Lu
M, Sachs JR, Bagchi A, Fridman A, Holder DJ, et al: Gene expression
profile of adipocyte differentiation and its regulation by
peroxisome proliferator-activated receptor-gamma agonists.
Endocrinology. 143:2106–2118. 2002.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Lukaszewski MA, Eberlé D, Vieau D and
Breton C: Nutritional manipulations in the perinatal period program
adipose tissue in offspring. Am J Physiol Endocrinol Metab.
305:E1195–E1207. 2013.PubMed/NCBI View Article : Google Scholar
|
|
48
|
Son YH, Ka S, Kim AY and Kim JB:
Regulation of adipocyte differentiation via microRNAs. Endocrinol
Metab (Seoul). 29:122–135. 2014.PubMed/NCBI View Article : Google Scholar
|
|
49
|
Saltiel AR and Kahn CR: Insulin signalling
and the regulation of glucose and lipid metabolism. Nature.
414:799–806. 2001.PubMed/NCBI View Article : Google Scholar
|
|
50
|
Peng XD, Xu PZ, Chen ML, Hahn-Windgassen
A, Skeen J, Jacobs J, Sundararajan D, Chen WS, Crawford SE, Coleman
KG and Hay N: Dwarfism, impaired skin development, skeletal muscle
atrophy, delayed bone development, and impeded adipogenesis in mice
lacking Akt1 and Akt2. Genes Dev. 17:1352–1365. 2003.PubMed/NCBI View Article : Google Scholar
|
|
51
|
Tang QQ, Gronborg M, Huang H, Kim JW, Otto
TC, Pandey A and Lane MD: Sequential phosphorylation of CCAAT
enhancer-binding protein beta by MAPK and glycogen synthase kinase
3beta is required for adipogenesis. Proc Natl Acad Sci USA.
102:9766–9771. 2005.PubMed/NCBI View Article : Google Scholar
|
|
52
|
Tanabe Y, Koga M, Saito M, Matsunaga Y and
Nakayama K: Inhibition of adipocyte differentiation by mechanical
stretching through ERK-mediated downregulation of PPARgamma2. J
Cell Sci. 117:3605–3614. 2004.PubMed/NCBI View Article : Google Scholar
|
